Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Between 1992 And 2005 Survival Rates For Elderly Receiving Hospital CPR Did Not Improve
A study of elderly patients receiving CPR in the hospital shows that rates of survival did not improve from 1992 to 2005. During that period, the proportion of hospital deaths preceded by CPR rose, and the proportion of patients who were successfully resuscitated and later discharged home fell. The researchers found that 18.3 percent of the Medicare beneficiaries age 65 and older who underwent in-hospital CPR survived to discharge.
generic viagra online
FDA Approves Tekturna HCT(R) As Initial Treatment In Patients Unlikely To Achieve Their Blood Pressure Goals With A Single Agent
The US Food and Drug Administration (FDA) has approved Tekturna HCT((R)) (aliskiren and hydrochlorothiazide) tablets as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals. Tekturna HCT is a single-pill combination of Tekturna((R)) (aliskiren), the first and only approved direct renin inhibitor, and the diuretic hydrochlorothiazide (HCTZ), one of the most commonly-used high blood pressure medications.
News of the day
Program Once Reserved For Alabama Inmates With HIV/AIDS Expanded To All Inmates
The Alabama Department of Corrections has expanded to all inmates a re-entry program that provides newly released inmates with HIV/AIDS "with information on obtaining licenses [and] other documents and preparing for returning to life outside prison," the AP/USA Today/Montgomery Advertiser reports (Hunter, 7/22). "In the past, prisoners at the end of their sentences were sent back into the free world with minimal assistance, not the in-depth services the inmates with HIV and AIDS had received," according to AP/WZTV.com. The expanded Alabama Prison Initiative will allow all inmates to enroll in classes that provide them with "practical tips" and guidance "that will hopefully help keep them from returning," the AP/WZTV.com reports (7/22). AIDS Alabama CEO Kathie Hiers said, "We"ve seen it help so much in the HIV community. They"re smart to take a good program and expand it" (Hunter, 7/22).
Nutrition

TR BioSurgical, LLC Develops Breakthrough Osteoarthritis Implant

TR BioSurgical, LLC, announced highly encouraging results using their new medical device (bioscaffold) in canine patients with advanced osteoarthritis. The new bioscaffold is implanted in or near diseased tissue and provides a structural matrix for local repair cells, such as stem cells or fibroblasts, to attach and heal tissue by local, physiological repair mechanisms. The new bioscaffold implant contains no drugs, cells or growth factors and is eventually resorbed by the infiltrating cells. The implant is made from a proprietary, copolymerized collagen and is sterile, cost effective, and non- immunogenic. Dr. Charles Pullen, lead investigator at the Animal Medical and Surgical Center, Scottsdale, Arizona, stated, "We have been evaluating canine patients with moderate to severe degenerative joint disease and pain. Without exception the owners reported a marked improvement within seven days of implantation and continued improvement thereafter in all dogs implanted with the bioscaffold, even with the discontinuation of all arthritis drugs and supplements. Dogs which required heavy medication to walk very short distances are walking, jumping, and running long distances just as they did before the onset of osteoarthritis with just one implant procedure with the bioscaffold". Dr. Jeff Kellerman, VP of R&D at TR BioSurgical, further added, "Few would debate that veterinary medicine is long overdue for safer, more effective options for managing osteoarthritis. Many of the drugs used in veterinary medicine can have harmful side effects and achieve suboptimal clinical benefits. Our team has developed a novel, cost effective and safe bioscaffold that has achieved optimal clinical outcomes in dogs that are poorly responsive to medical management." About Canine Osteoarthritis Osteoarthritis is the leading cause of disability in dogs and is estimated to affect twenty five percent of the dog population, making it one of the single largest markets in veterinary medicine. Osteoarthritis is a complex disorder involving cartilage, subchondral bone, and synovium leading to various degrees of inflammation and physical disability. Canine arthritis can mimic the progressive inflammatory and structural changes observed in human osteoarthritis, making it an excellent comparative model for human orthopedics and degenerative joint disease. TR BioSurgical, LLC


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009